A randomized, double-blind study compari
โ
Koo; FOR THE OLP302 STUDY GROUP
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 787 KB
This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose